Akèy › Limfòm folikilè › Wisconsin › Milwaukee
Etid klinik pou Limfòm folikilè nan Milwaukee, WI
19 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Milwaukee (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Ap rekriteFaz 3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi lwen
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi lwen
- ak 3 plis
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Ap rekriteEtid obsèvasyon
- Children's Hospital of Wisconsin, Milwaukee
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Ap rekriteVolontè an sante akeyi
- Vivent Health, Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Ap rekriteFaz 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Ap rekriteFaz 3
- Research Site, Milwaukee
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Ap rekriteFaz 2
- Research Site, Milwaukee
A Study of ARC-02 in B-cell NHL
Ap rekriteFaz 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- Medical College of Wisconsin, Milwaukee
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Ap rekriteFaz 3
- Prohealth Care Inc, Waukesha · 17 mi lwen
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Ap rekriteFaz 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Ap rekriteFaz 1
- Medical College of Wisconsin, Milwaukee
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Ap rekriteFaz 2
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Ap rekriteFaz 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
Ap rekriteFaz 1
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Ap rekriteEtid obsèvasyon
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Milwaukee
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Ap rekriteEtid obsèvasyon
- CIBMTR, Milwaukee
Etid Limfòm folikilè nan lòt vil
- New York City, NY24 etid
- Nashville, TN18 etid
- Houston, TX18 etid
- Boston, MA17 etid
- Baldwin Park, CA16 etid
- Seattle, WA15 etid
- Durham, NC15 etid
- Columbus, OH13 etid
- Salt Lake City, UT13 etid
- San Antonio, TX12 etid
- Chicago, IL12 etid
- Philadelphia, PA12 etid
Lòt etid nan Milwaukee
- Kansè nan tete23 etid
- Kansè Poumon ki pa ti selil22 etid
- Kansè (tout kalite)22 etid
- Kansè poumon21 etid
- Myelom Miltip21 etid
- Kansè pwostat20 etid
- Kansè pankreyas18 etid
- Limfòm Non-Hodgkin18 etid
- Kansè ovè17 etid
- Leksemi mieloïd egi17 etid
- Limfòm Burkitt16 etid
- Ensifizyans kadyak16 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.